CQC Hands Out a Clean Bill to the Hospitals of Pennine Acute Hospitals NHS Trust

CQC Hands Out a Clean Bill to the Hospitals of Pennine Acute Hospitals NHS TrustIn January, the Care Quality Commission (CQC) conducted a series of spot checks at all four hospitals run by the Pennine

SAHO’s Offer Rejected

SAHO’s Offer RejectedReports are suggesting that The Saskatchewan Association of Health Organizations have come up with a new strategy.

Profits of Abano Healthcare down

Abano-HealthcareHalf-yearly profits of Abano Healthcare have gone down and the company says that the conditions are still very challenging and would be the same.

For six months ending November, the listed firm saw its profit at $2.8 million, 1/5 of the same last year. Revenues also declined by 15 per cent to be at $86.7 million.

Quetiapine from Dr. Reddy's Laboratories will be Fully Funded by Pharmac

Dr-Reddys-LaboratoriesA drug funder of the New Zealand Government, Pharmac is ready to give funds to the Indian firm Dr. Reddy's Laboratories, which has made Quetiapine drug.

Pharmac has said that the subsidy for Seroquel, a brand of the antipsychotic drug Quetiapine will be reduced from 1 October and in its place they will introduce the new brand of Quetiapine made by the Indian pharma giant Dr. Reddy's Laboratories.

Medtronics tones down forecast despite good performance

Medtronics tones down forecast despite good performanceMedical equipment maker, Medtronics has shown better than expected profit figures but has on the same hand reduced its forecasts figures for the crest of the year.

The firm earned $830 million during the past quarter which is higher than $445 million that it was able to do during the same quarter last year. This means that against 40 cents per share the earnings have now gone up to 76 cents per share.

Medtronic to buy Osteotech

Medtronic-OsteotechWorld's largest medical device maker, Medtronic has agreed to buy out Osteotech Inc for $123 million. This company is into the business of bone grafting.

If the deal goes through then the addition of Osteotech will be done to the biologics business.

As per the news reports, Medtronic has offered to pay $6.50 per share for the company. This is 65 per cent premium on the closing share price of Osteotech of $3.94.